Celiac Disease, or Gluten intolerance, is an immune response in the small intestine. When gluten is eaten, the immune system attacks the places in the small intestine that absorbs nutrients. Overtime, the reaction causes inflammation which damages the lining of the small intestine and prevents absorption of certain nutrients. The symptoms of Celiac disease include abdominal pain, nausea, and unexplained weight loss; these symptoms can become more severe because of the nutrients not being absorbed. Celiac disease can arise at any point in a person’s life and there is no cure. Celiac disease can be treated with a gluten-free diet which will let the lining of the small intestine heal. Also, multi-vitamins are sometimes prescribed to correct the previous deficiencies.
Celiac Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Celiac Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 3628 products for the study of Celiac Disease that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Celiac Disease is also known as celiac disease, coeliac disease, celiac sprue, gluten-sensitive enteropathy, celiac disease (disorder), nontropical sprue, celiac disease nos (disorder), steatorrhoea - idiopathic, idiopathic steatorrhea, gluten enteropathy, steatorrhea, sprue.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.